Tinavi Medical Technologies Co Ltd (688277) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Tinavi Medical Technologies Co Ltd (688277) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.50 Million ≈ $3.59 Million USD) by net assets (CN¥1.29 Billion ≈ $189.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tinavi Medical Technologies Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Tinavi Medical Technologies Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Tinavi Medical Technologies Co Ltd for a breakdown of total debt and financial obligations.

Tinavi Medical Technologies Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tinavi Medical Technologies Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Winmark Corporation
NASDAQ:WINA
-0.465x
Ecovyst Inc
NYSE:ECVT
0.091x
Thangamayil Jewellery Limited
NSE:THANGAMAYL
-0.093x
Centuria Industrial REIT
AU:CIP
0.020x
Sinomach Automobile Co Ltd
SHG:600335
-0.073x
Henan Zhongyuan Expressway Co Ltd
SHG:600020
0.063x
Ingles Markets Incorporated
NASDAQ:IMKTA
0.023x
World Kinect Corporation
NYSE:WKC
0.026x

Annual Cash Flow Conversion Efficiency for Tinavi Medical Technologies Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Tinavi Medical Technologies Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Tinavi Medical Technologies Co Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.28 Billion
≈ $187.32 Million
CN¥-98.65 Million
≈ $-14.44 Million
-0.077x +44.06%
2023-12-31 CN¥1.24 Billion
≈ $181.09 Million
CN¥-170.50 Million
≈ $-24.95 Million
-0.138x -75.95%
2022-12-31 CN¥1.12 Billion
≈ $163.54 Million
CN¥-87.51 Million
≈ $-12.80 Million
-0.078x -7.51%
2021-12-31 CN¥1.07 Billion
≈ $156.22 Million
CN¥-77.76 Million
≈ $-11.38 Million
-0.073x -29.85%
2020-12-31 CN¥1.03 Billion
≈ $150.22 Million
CN¥-57.58 Million
≈ $-8.43 Million
-0.056x -262.91%
2019-12-31 CN¥596.34 Million
≈ $87.26 Million
CN¥20.53 Million
≈ $3.00 Million
0.034x +46.76%
2018-12-31 CN¥560.61 Million
≈ $82.04 Million
CN¥13.15 Million
≈ $1.92 Million
0.023x -30.62%
2017-12-31 CN¥169.41 Million
≈ $24.79 Million
CN¥5.73 Million
≈ $838.18K
0.034x +114.13%
2016-12-31 CN¥136.62 Million
≈ $19.99 Million
CN¥-32.70 Million
≈ $-4.78 Million
-0.239x -216.74%
2015-12-31 CN¥203.98 Million
≈ $29.85 Million
CN¥41.82 Million
≈ $6.12 Million
0.205x +132.02%
2014-12-31 CN¥52.84 Million
≈ $7.73 Million
CN¥-33.84 Million
≈ $-4.95 Million
-0.640x -460.95%
2013-12-31 CN¥29.60 Million
≈ $4.33 Million
CN¥-3.38 Million
≈ $-494.53K
-0.114x --

About Tinavi Medical Technologies Co Ltd

SHG:688277 China Medical Instruments & Supplies
Market Cap
$1.33 Billion
CN¥9.08 Billion CNY
Market Cap Rank
#7880 Global
#1965 in China
Share Price
CN¥19.92
Change (1 day)
+4.35%
52-Week Range
CN¥11.84 - CN¥27.95
All Time High
CN¥141.60
About

Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more